Top scientists and BD execs craft Cullinan, a $150 million R&D portfolio shop focused on cancer
Close to six years ago, then Amgen R&D chief Roger Perlmutter told me he had been “carrying a torch for (CSO) Patrick Baeuerle at Micromet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
